105 related articles for article (PubMed ID: 16544586)
1. Safety and pharmacoeconomics of a cluster administration of mite immunotherapy compared to the traditional one.
Mauro M; Russello M; Alesina R; Sillano V; Alessandrini A; Dama A; Passalacqua G; Senna G
Eur Ann Allergy Clin Immunol; 2006 Jan; 38(1):31-4. PubMed ID: 16544586
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of cluster and conventional immunotherapy schedules with dermatophagoides pteronyssinus in the treatment of persistent allergic rhinitis.
Zhang L; Wang C; Han D; Wang X; Zhao Y; Liu J
Int Arch Allergy Immunol; 2009; 148(2):161-9. PubMed ID: 18802361
[TBL] [Abstract][Full Text] [Related]
3. Safety of two cluster schedules for subcutaneous immunotherapy in allergic rhinitis or asthma patients sensitized to inhalant allergens.
Pfaar O; Klimek L; Fischer I; Sieber J; Amoroso S; Moreno Aguilar C; Shah K; Mösges R
Int Arch Allergy Immunol; 2009; 150(1):102-8. PubMed ID: 19339808
[TBL] [Abstract][Full Text] [Related]
4. Safety, tolerability and efficacy of sublingual allergoid immunotherapy with a 4-day shortened build-up phase.
Giordano T; Quarta C; Bruno ME; Falagiani P; Riva G
Eur Ann Allergy Clin Immunol; 2006 Nov; 38(9):310-2. PubMed ID: 17191751
[TBL] [Abstract][Full Text] [Related]
5. Accelerated immunotherapy schedules: review of efficacy and safety.
Cox L
Ann Allergy Asthma Immunol; 2006 Aug; 97(2):126-37; quiz 137-40, 202. PubMed ID: 16937741
[TBL] [Abstract][Full Text] [Related]
6. [Cluster immunotherapy in allergic rhinoconjunctivitis].
Klimek L; Pfaar O
MMW Fortschr Med; 2011 Feb; 153(7):34-6. PubMed ID: 21648138
[No Abstract] [Full Text] [Related]
7. Side-effects of injective allergen immunotherapy administered to intermittent or persistent allergic rhinitis patients.
Rogala B; Markiewicz-Bendkowska IB; Brzoza Z; Glück J; Oleś E
Rhinology; 2007 Jun; 45(2):134-9. PubMed ID: 17708460
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy--traditional.
Koshkareva YA; Krouse JH
Otolaryngol Clin North Am; 2011 Jun; 44(3):741-52, x. PubMed ID: 21621058
[TBL] [Abstract][Full Text] [Related]
9. [Study on safty of standardized specific mite-allergen immunotherapy to children with allergic rhinitis and/or asthma].
Wu Y; Long Z; Huang Y; Huang X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Jul; 25(14):641-4. PubMed ID: 22032122
[TBL] [Abstract][Full Text] [Related]
10. Safety of an ultra-rush immunotherapy build-up schedule with therapeutic vaccines containing depigmented and polymerized allergen extracts.
Casanovas M; Martín R; Jiménez C; Caballero R; Fernández-Caldas E
Int Arch Allergy Immunol; 2006; 139(2):153-8. PubMed ID: 16374026
[TBL] [Abstract][Full Text] [Related]
11. Safety of cluster specific immunotherapy with a modified high-dose house dust mite extract.
Nieto García A; Nevot Falcó S; Carrillo Díaz T; Cumplido Bonny JA; Izquierdo Calderón JP; Hernández-Peña J
Eur Ann Allergy Clin Immunol; 2013 May; 45(3):78-83. PubMed ID: 23862396
[TBL] [Abstract][Full Text] [Related]
12. Double-blind comparative study of cluster and conventional immunotherapy schedules with Dermatophagoides pteronyssinus.
Tabar AI; Echechipía S; García BE; Olaguibel JM; Lizaso MT; Gómez B; Aldunate MT; Martin S; Marcotegui F
J Allergy Clin Immunol; 2005 Jul; 116(1):109-18. PubMed ID: 15990782
[TBL] [Abstract][Full Text] [Related]
13. Long-term efficacy of sublingual immunotherapy in patients with perennial rhinitis.
Tahamiler R; Saritzali G; Canakcioglu S
Laryngoscope; 2007 Jun; 117(6):965-9. PubMed ID: 17545861
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the long-term efficacy of subcutaneous and sublingual immunotherapies in perennial rhinitis.
Tahamiler R; Saritzali G; Canakcioglu S; Ozcora E; Dirican A
ORL J Otorhinolaryngol Relat Spec; 2008; 70(3):144-50. PubMed ID: 18391573
[TBL] [Abstract][Full Text] [Related]
15. Olerance of a cluster schedule with a house dust mite extract quantified in mass units: multicentre study.
Tabar AI; Fernández-Távora L; Alonso R; Castillo R; Cisteró-Bahima A; de la Torre-Morin F; Fernández J; García-Figueroa BE; Fernández S; García-González JJ; García-Robaina JC; Moreno F; Lobatón P; Sánchez-Machín I; de la Torre-Martínez F
J Investig Allergol Clin Immunol; 2004; 14(3):193-7. PubMed ID: 15552712
[TBL] [Abstract][Full Text] [Related]
16. [Comparative study on cluster and conventional immunotherapy with Dermatophagoides pteronyssinus in patients with allergic rhinitis].
Wang CS; Zhang W; Wang XD; Xi L; Ouyang YH; Zhao Y; Zhang L
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Dec; 46(12):981-5. PubMed ID: 22336008
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy.
Rossi RE; Monasterolo G; Coco G; Silvestro L; Operti D
Vaccine; 2007 Jan; 25(5):957-64. PubMed ID: 17045368
[TBL] [Abstract][Full Text] [Related]
18. Quantitative assessment of the compliance with once-daily sublingual immunotherapy in children (EASY project: evaluation of a novel SLIT formulation during a year).
Passalacqua G; Musarra A; Pecora S; Amoroso S; Antonicelli L; Cadario G; Di Gioacchino M; Lombardi C; Ridolo E; Sacerdoti G; Schiavino D; Senna G
Pediatr Allergy Immunol; 2007 Feb; 18(1):58-62. PubMed ID: 17295800
[TBL] [Abstract][Full Text] [Related]
19. Survey on the safety of a no-updosing regimen of sublingual immunotherapy.
Musarra A; Cilia M; Pecora S; Passalacqua G
Eur Ann Allergy Clin Immunol; 2006 Nov; 38(9):313-4. PubMed ID: 17191752
[No Abstract] [Full Text] [Related]
20. Cluster immunotherapy with a glutaraldehyde-modified mixture of grasses results in an improvement in specific nasal provocation tests in less than 2.5 months of treatment.
Subiza J; Feliú A; Subiza JL; Uhlig J; Fernández-Caldas E
Clin Exp Allergy; 2008 Jun; 38(6):987-94. PubMed ID: 18445082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]